Celsion Stock Predictions

Healthcare > Biotechnology

Buy CLSN

*Your capital is at risk

$1.56

+0.0600 (+4.00%)

At Close: Jan 27, 2023

Currently predicting for Mon, 8 Jun 2026

CLSN Prediction Chart

CLSN Predictions History

Latest community submissions for CLSN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Andrew.P.83148	Jul 2, 2018	$2.95 -4.22%	$3.08	X	95.80%	0
TommyCFA	Jul 2, 2018	$3.50 +13.64%	$3.08	X	86.40%	0
Balagurubaran	Dec 8, 2017	$2.40 -16.08%	$2.86	X	83.90%	0
Shrayda	Dec 8, 2017	$3.00 +4.90%	$2.86	X	95.10%	0
JS Pro	Oct 26, 2017	$3.08 +7.69%	$2.86	X	92.30%	0
poiklp	Oct 26, 2017	$2.90 +1.40%	$2.86	X	98.60%	1
JuanC Villegas Pro	Oct 26, 2017	$3.03 +5.94%	$2.86	X	94.10%	0
michael.schanding.10551	Oct 26, 2017	$3.07 +7.34%	$2.86	X	92.70%	0
JS Pro	Oct 24, 2017	$3.45 +0.88%	$3.42	X	99.10%	2
JuanC Villegas Pro	Oct 24, 2017	$3.26 -4.68%	$3.42	X	95.30%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLSN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CELSION CORPORATION

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company als...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by